Tilray Stock News

The Best Daily Overview Of The Cannabis Space Tilray (TLRY) - Analyst at Canaccord upgrades the stock to Bu…

On Thursday, HEXO Corp. (NASDAQ: HEXO ) finalized a strategic partnership with Tilray Brands, Inc. (NASDAQ: TLRY ), which includes a new debt financing agreement under which the Canadian cannabis giant agreed to acquire $211 million of senior secured convertible notes that were initially issued by HEXO to HT Investments MA LLC at 95% of face value. The deal brings together Canada’s top two cannabis market share leaders and is expected to create efficiencies of up to CA$50 million ($39.57 million) within two years, which will be shared equally between the two entities. The Analyst Cantor Fitzgerald’s analyst Pablo Zuanic maintained a ‘Neutral’ rating on Tilray’s stock, keeping the price target of $6.9 unchanged. The analyst stayed ‘Neutral’ on HEXO’s stock, lowering the price target to CA$0.90 from C$1.20 given the higher share count. The Thesis While the terms of the notes are significantly more favorable to HEXO and will enable the company to strengthen its balance sheet and accelerate its transformation into a cash flow …

In the wake of the new strategic alliance formed by Tilray (TLRY) and Hexo (HEXO), Canaccord Genuity raised its recommendations on the two Canadian licensed producers on Friday, citing…

The Best Daily Pre-Market Overview Of The Cannabis Space Here are the highlights of today''s episode of Cannabis Daily: HEXO Corp. HEXO HEXO+7.54% is finalizing a strategic partnership with Tilray Brands, Inc. TLRY-4.67% which includes Tilray acquiring $211 million … Full story available on Benzinga.com

Hexo (TSX:HEXO)(NASDAQ:HEXO) stock soared 18% after news that its debt would be taken over by Tilray (TSX:TLRY)(NASDAQ:TLRY) stock. The post Why Hexo Stock Soared 18% on Thursday appeared first on The Motley Fool Canada .

Tilray Inc. (NASDAQ: TLRY ) shares … Full story available on Benzinga.com

Tilray is acquiring a portion of Hexo''s debt. Here''s what investors in HEXO, TLRY stocks should know about the collaboration between the two.

Tilray Brands Inc. undefinedundefined said Thursday it would buy up to $211 million of Hexo Corp. undefinedundefined senior secured convertible notes held by…

Canadian licensed producers, Tilray Brands (TLRY) and Hexo Corp

Tilray Brands Inc. said Thursday it would buy up to C$211 million ($167 million) of Hexo Corp. senior secured convertible notes held by HT Investments MA LLC as part of a strategic alliance between the two cannabis companies. Tilray would have the right to convert the debt into stock at a price of 90 cents per Hexo share. The transaction will provide Tilray with a "significant equity ownership position" in Hexo, the company said. Hexo would pay Tilray about C$20 million in interest payments the first year, or about 4 cents a share in earnings. Tilray said it will also realize about C$50 million in efficiency savings within two years. Hexo said the deal will provide it with more favorable terms on the debt and will allow the company to strengthen its balance sheet and "accelerate its transformation into a cash flow positive business within the next four quarters." Shares of Hexo rose 27% in premarket trades, but remained well under $1 a share. Tilray dipped 0.2%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move.

Tilray to Acquire Hexo Corp.’s Senior Secured Convertible Notes Tilray to Acquire Hexo Corp.’s Senior Secured Convertible Notes

Sundial Growers Inc (NASDAQ: SNDL ) was trading slightly higher on Wednesday, while Tilray, Inc (NASDAQ: TLRY ) was trading down about 2%. The overall sector has been all but demolished since the high times of 2018, when Canada legalized cannabis at the federal level, and the beginning of 2021, when President Joe Biden’s inauguration led many to believe federal legalization in the U.S. may be on the horizon. Sundial has plummeted 96% from its Aug. 1, 2019 all-time high of $59.25, while Tilray has plunged about 98% from its Sept. 19, 2018 all-time high of $300. Even though the stocks shot up again in February 2021, with Sundial reaching a high of $3.96 and Tilray soaring up to the $67 level on Feb. 10, the sector has failed to sustain any long-term bull cycle. Unless the U.S. decides to legalize cannabis federally, there is likely little in terms of news that could help the sector make a meaningful reversal. However, the stocks are beginning to show some characteristics that could make them candidates for a short squeeze.

Tilray''s (NASDAQ: TLRY ) subsidiary Manitoba Harvest, a hemp foods brand will unveil its new product lineup at the upcoming Natural Products Expo West, to be held March 10-12 in Anaheim, CA . Attendees are invited to experience the power of hemp food as Manitoba Harvest introduces a line of Hemp Protein items blended with other powerful plants like Matcha and … Full story available on Benzinga.com

Photo by David Gabric on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Wondering whether a clone or a seed produces the best harvest is likely not a thought that occurs to the layperson, but it’s one that cannabis producers spend significant time considering. Picking between seed and clone affects almost everything about the final cannabis product. The source of the cannabis plant affects the potency of the flower, the quantity and size of the buds, and the growth-to-maturity process, all components crucial to creating a quality cannabis product. Despite decades of cannabis cultivation, debate on which of the two is “the best” source remains heated. Many seed growers, for example, argue that their plants are more pest resistant and have larger buds than their clone-grown counterparts, and some clone-growers argue the exact opposite. On a commercial scale, the divide is smaller. The majority of cannabis producers employ clone-based cannabis production and use seeds to pick strong “mothers.” Marijuana Company of America Inc. (OTC: MCOA ), for example, recently acquired VBF Brands Inc. , a clone-focused cannabis producer.

Image provided by OMID Holdings This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Almost four years after the cannabis boom , the industry has made great strides in the pursuit of federal acceptance and regulation. The 2018 Farm Bill , Assembly Bill No. 45 , and States Reform Act are just a few examples of the United States’ steady march toward a more cannabis-friendly nation. However, as investors realized how long the march would take, attention toward the industry dwindled, leaving a library of potentially overlooked investment candidates. While most investors are familiar with boom-and-bust movers like Tilray Inc. (NASDAQ: TLRY ) and Canopy Growth Corp. (NASDAQ: CGC ), smaller – but profitable – operators like OMID Holdings Inc. (OTC: OMID ) are also out there. Since 2015, OMID has been a health and wellness manufacturer with a goal of innovating and … Full story available on Benzinga.com